Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-07-09
2000-02-29
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514338, 5143335, A61K 3134
Patent
active
060309989
ABSTRACT:
Disclosed herein are methods for treating human patients suffering from arrhythmia comprising administration to the human a solutions containing a 3-diethylaminoethoxybenzoyl-benzofuran in acetate buffer.
REFERENCES:
patent: 3248401 (1966-04-01), Tondeur et al.
patent: 4791137 (1988-12-01), Descamps et al.
patent: 5234949 (1993-08-01), Ehrenpreis et al.
Anderson, "Current understanding of Iidocaine as an antiarrhythmic agent: A review," Clin. Ther. (1984) 6(2):125-41.
Bopp et al., "Acute hemodynamic effects of intravenous amiodarone in patients with coronary artery disease," J. Cardiovasc. Pharmacol., (1985) 7(2):286-9.
Escoubet et al., "Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations," Am. J. Cardiol., (1985) 55(6):696-702.
Gallik et al., "Hemodynamic and electrocardiographic effects of amio-aqueous, a new formulation of intravenous amiodarone," PACE Pacing and Clinical Electrophysiology, P1120 abs 283A (1997) 20(4) Part II.
Gallik et al., "Favorable hemodynamic effect of amio-aqueous, a new formulation of intravenous amiodarone," Circulation, (1997) 96(8)Suppl:I-383.
Gough et al., "Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs," J. Cardiovasc. Pharmacol., (1982) 4(3):375-80.
Hardman et al., editors, Goodman & Gilman's Pharmacological Basis of Therapeutics, 9th Edition, McGraw-Hill, New York (1996) p. 866.
Hargarten, et al., "Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain," Annals of Emergency Medicine, (1990) 19(11):1274-9.
Kadish et al., "The use of intravenous amiodarone in the acute therapy of life-threatening tacharrhythmias," Prog. Cardiovasc. Dis., (1989) 31(4):281-94.
Kosinski et al., "Hemodynamic effects of intravenous amiodarone," J. Am. Coll. Cardiol., (1984) 4(3):565-70.
Kowey et al., "Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation," Circulation, (1995) 92(11):3255-63.
Levine et al., "Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias," J. Am. Choll. Cardiol., (1996) 27(1):67-75.
Morady et al., "Clinical characteristics and results of electrophysiologic testing in young adults with ventricular tachycardia or ventricular fibrillation," Am. Heart J., (1983) 106(6):1306-14.
Mostow et al., "Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone," Circulation, (1986) 73(6):1231-8.
Physicians' Desk Reference, (1992) p. 2446.
Ravin et al., "Micelle formation and its relationship to solubility behavior of 2-butyl-3-benzofuranyl-4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl ketone hydrochloride," J. Pharm. Sci., (1975) 64(11):1830-3.
Remington's Pharmaceutical Sciences, 17.sup.th Edition, (1985) pp. 1521-1523.
Remme et al., "Hemodynamic effects of tolerability of intravenous amiodarone in patients with impaired left ventricular function," Am. Heart J., (1992) 122:96-103.
Scheinman et al., "Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias," Circulation, (1995) 92(11):3264-72.
Somberg, "Intravenous amiodarone," Clinical Progress in Electrophysiology and Pacing, (1986) 4(5):430-5.
Somberg et al., "A new aqueous preparation of amiodarone", Circulation, (1995) 92(8)Suppl:I-195.
Somberg et al., "A new aqueous preparation of amiodarone," J. of Inv. Med. (1995) 43(3)Suppl:A-430.
Torres-Arrault et al., "Electrophysiological effects of tween 80 in the myocardium and specialized conduction system of the canine heart," J. Electrocardiology, (1984) 17(2):145-152.
Academic Pharmaceuticals, LP
Reamer James H.
LandOfFree
Methods for treating arrhythmia using acetate buffer solutions o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating arrhythmia using acetate buffer solutions o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating arrhythmia using acetate buffer solutions o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-683456